• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于氮杂环丁烷的二肽基肽酶IV(DPP IV)抑制剂。

Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV).

作者信息

Ferraris Dana, Belyakov Sergei, Li Weixing, Oliver Eddie, Ko Yao-Sen, Calvin David, Lautar Susan, Thomas Bert, Rojas Camilo

机构信息

Senior Scientist II, MGI Pharma, 6611 Tributary Street, Baltimore, MD 21224, USA.

出版信息

Curr Top Med Chem. 2007;7(6):597-608. doi: 10.2174/156802607780090993.

DOI:10.2174/156802607780090993
PMID:17352680
Abstract

The structure-activity relationships of azetidine-based DPP IV inhibitors will be discussed in detail in the following review. The azetidine-based DPP IV inhibitors can be divided into three main subtypes, the 2-cyanoazetidines, 3-fluoroazetidines and 2-ketoazetidines. These subtypes have been explored and structure-activity relationships have been established by several groups. Several compounds within each of these subtypes display sub micromolar potency against DPP IV. The most potent cyanoazetidines and ketoazetidines have large, hydrophobic amino acid groups bound to the azetidine nitrogen and display activities below 100 nM. DPP IV inhibition is not sensitive to stereochemistry at the 2-position as both 2-(R)- and 2-(S)-cyano and -keto azetidines display similar inhibitory potencies. While these "warhead"-based cyano- and ketoazetidines have the potential for covalent, bond-forming inhibition, they can also react to internally cyclize into inactive ketopiperazines and dihydroketopyrazine. Thus, chemical instability was also explored for compounds in these two subtypes and certain members of the cyanoazetidine series display aqueous stability comparable to the closely related cyanopyrrolidines. Select 3-fluoroazetidines also display inhibitory potencies below 1 microM without the propensity for cyclization and chemical instability associated with the other subseries.

摘要

氮杂环丁烷类二肽基肽酶IV(DPP IV)抑制剂的构效关系将在以下综述中详细讨论。氮杂环丁烷类DPP IV抑制剂可分为三个主要亚型,即2-氰基氮杂环丁烷、3-氟氮杂环丁烷和2-氧代氮杂环丁烷。几个研究小组已经对这些亚型进行了探索并建立了构效关系。这些亚型中的几种化合物对DPP IV显示出亚微摩尔级的效力。最有效的氰基氮杂环丁烷和氧代氮杂环丁烷在氮杂环丁烷氮原子上连接有大的疏水性氨基酸基团,其活性低于100 nM。DPP IV抑制对2-位的立体化学不敏感,因为2-(R)-和2-(S)-氰基及氧代氮杂环丁烷均显示出相似的抑制效力。虽然这些基于“弹头”的氰基和氧代氮杂环丁烷有形成共价键抑制的潜力,但它们也会发生内部环化反应生成无活性的酮哌嗪和二氢酮吡嗪。因此,也对这两个亚型的化合物的化学稳定性进行了研究,氰基氮杂环丁烷系列的某些成员显示出与密切相关的氰基吡咯烷相当的水稳定性。一些3-氟氮杂环丁烷也显示出低于1 μM的抑制效力,且没有与其他子系列相关的环化倾向和化学不稳定性。

相似文献

1
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV).基于氮杂环丁烷的二肽基肽酶IV(DPP IV)抑制剂。
Curr Top Med Chem. 2007;7(6):597-608. doi: 10.2174/156802607780090993.
2
Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors.吡咯烷酮和氮杂环丁烷酮作为强效二肽基肽酶IV(DPP IV)抑制剂。
Bioorg Med Chem Lett. 2004 Nov 15;14(22):5579-83. doi: 10.1016/j.bmcl.2004.08.057.
3
11 Years of cyanopyrrolidines as DPP-IV inhibitors.作为二肽基肽酶-IV抑制剂的氰基吡咯烷类化合物的11年研究历程。
Curr Top Med Chem. 2007;7(6):579-95. doi: 10.2174/156802607780091000.
4
Aromatic heterocycle-based DPP-IV inhibitors: xanthines and related structural types.基于芳香杂环的二肽基肽酶-IV抑制剂:黄嘌呤及相关结构类型。
Curr Top Med Chem. 2007;7(6):569-78. doi: 10.2174/156802607780091073.
5
Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.与二肽基肽酶IV相关的脯氨酰肽酶:特异性抑制剂在药物研发中的潜力
Curr Top Med Chem. 2007;7(6):621-35. doi: 10.2174/156802607780091046.
6
A potent dipeptide inhibitor of dipeptidyl peptidase IV.一种有效的二肽基肽酶IV二肽抑制剂。
Bioorg Med Chem Lett. 1998 Jun 16;8(12):1537-40. doi: 10.1016/s0960-894x(98)00259-5.
7
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease.基于结构设计新型系列丙型肝炎病毒NS3/4A丝氨酸蛋白酶的氮杂环丁烷抑制剂
Bioorg Med Chem Lett. 2014 Sep 15;24(18):4444-4449. doi: 10.1016/j.bmcl.2014.08.002. Epub 2014 Aug 9.
8
New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors.新型氟化吡咯烷和氮杂环丁烷酰胺作为二肽基肽酶IV抑制剂
Bioorg Med Chem Lett. 2005 Nov 1;15(21):4770-3. doi: 10.1016/j.bmcl.2005.07.026.
9
Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.羧苄基取代的8-(3-(R)-氨基哌啶-1-基)-7-(2-氯/氰基苄基)-3-甲基-3,7-二氢嘌呤-2,6-二酮作为二肽基肽酶IV(DPP-IV)抑制剂的合成及强效抑制活性
Bioorg Med Chem Lett. 2015 May 1;25(9):1872-5. doi: 10.1016/j.bmcl.2015.03.048. Epub 2015 Mar 24.
10
Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.具有二肽基肽酶IV(DPP-IV)抑制活性的乳蛋白衍生肽的构效关系建模
Peptides. 2016 May;79:1-7. doi: 10.1016/j.peptides.2016.03.005. Epub 2016 Mar 15.

引用本文的文献

1
Stereo- and Enantioselective Addition of Organolithiums to 2-Oxazolinylazetidines as a Synthetic Route to 2-Acylazetidines.将有机锂试剂对2-恶唑啉基氮杂环丁烷进行立体和对映选择性加成作为合成2-酰基氮杂环丁烷的一条路线。
Front Chem. 2019 Sep 10;7:614. doi: 10.3389/fchem.2019.00614. eCollection 2019.
2
Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.沙格列汀:一种用于治疗2型糖尿病的选择性二肽基肽酶-4抑制剂。
Clin Med Insights Endocrinol Diabetes. 2011;4:1-12. doi: 10.4137/CMED.S5114. Epub 2011 Jan 12.
3
Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.
采用互补定量质谱方法对 2 型糖尿病和非糖尿病患者的人肌管进行特征分析。
Mol Cell Proteomics. 2011 Sep;10(9):M110.006650. doi: 10.1074/mcp.M110.006650. Epub 2011 Jun 22.